Novartis cannot block drugmaker MSN Pharmaceuticals from launching a generic version of its blockbuster heart-failure drug ...

A Delaware federal judge has ruled that Novartis cannot prevent MSN Pharmaceuticals from introducing a generic version of its ...

Wockhardt will exit its loss-making US generic business to focus on antibiotics and diabetes care. The company filed for ...

Wockhardt Ltd on July 11 said it has decided to exit US generic pharmaceutical segment to unlock capital for high-impact ...

This multi-state settlement addresses makers of generic versions of opioids and is up to $720 million, officials said.

By exiting the US generics space, the company aims to redirect capital and executive focus toward two key growth areas: novel ...

Indian drug firm Wockhardt announces exit from its loss-incurring US generic business to concentrate on innovative ...

Trying to quickly turn a browser extension into a new revenue stream can backfire—common missteps can damage trust and tank ...

Since June, the group has blown up in America with an album at No. 3 on Billboard and a hit single climbing up the Hot 100.

Bausch Health Companies Inc. (NYSE:BHC) is one of the 13 Best Healthcare Stocks to Buy Under $10. On July 9, Bausch Health ...

Eight pharmaceutical companies agree to $720M deal as state’s legal campaign against opioid profiteers tops $1.1B in ...

While the total number of drug shortages in the U.S. appears to be decreasing in 2025, some shortages of essential medications have yet to be resolved. Erin Fox, PharmD, senior pharmacy director at ...